After the recent announcement of COVID-19 vaccine efficacy in clinical trials by several
manufacturers for protection against severe disease, a comprehensive post-efficacy strategy …

The recent outbreak of CoVID-19 is declared as a global public health emergency of
international concern by the World Health Organization (WHO). A fresh figure of 2268011 …

Influenza A virus is one of the most important zoonotic pathogens that can cause severe
symptoms and has the potential to cause high number of deaths and great economic loss …

Abstract Background/Aim Pfizer-BioNTech, Moderna, and Johnson & Johnson's Janssen are
the 3 COVID-19 vaccines authorized for emergency use in the United States. This study …

Background Despite the high risk and economic burden of influenza-related diseases, about
one-third of adults aged 65 and older still forego annual influenza vaccination. Mass media …

Respiratory disease caused by RSV infection is recognized as a severe public health issue
in infants, young children and elderly with no specific treatment option. Vaccination may be …

Vaccines targeting SARS-CoV-2 have been shown to be highly effective; however, the
breadth against emerging variants and the longevity of protection remains unclear …

Influenza viruses pose a significant threat to human health. They are responsible for a large
number of deaths annually and have a serious impact on the global economy. There are …

Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are
common emerging pathogens that cause respiratory tract infections in humans. In December …

The current pandemic has brought a renewed appreciation for the critical importance of
vaccines for the promotion of both individual and public health. Influenza vaccines have …